Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

CEO

ISIN

BE0003874915

Listings

0 Comments

Share your thoughts

FAQ

What is Fagron NV stock price today?▼

The current price of FAGR.AS is €6.42 EUR — it has decreased by -65.79% in the past 24 hours. Watch Fagron NV stock price performance more closely on the chart.

What is Fagron NV stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Fagron NV stocks are traded under the ticker FAGR.AS.

What is Fagron NV market cap?▼

Today Fagron NV has the market capitalization of 468.95M

When is the next Fagron NV earnings date?▼

Fagron NV is going to release the next earnings report on July 30, 2026.

What is Fagron NV revenue for the last year?▼

Fagron NV revenue for the last year amounts to 2.38B EUR.

What is Fagron NV net income for the last year?▼

FAGR.AS net income for the last year is 227.6M EUR.

Does Fagron NV pay dividends?▼

Yes, FAGR.AS dividends are paid annual. The last dividend per share was 0.35 EUR. As of today, Dividend Yield (FWD)% is 5.45%.

When did Fagron NV complete a stock split?▼

Fagron NV has not had any recent stock splits.